Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Allan D. Angerio"'
Autor:
Allan D. Angerio
Publikováno v:
Critical Care Nursing Quarterly. 32:159-162
Heart disease is the leading cause of morbidity and mortality in the United States. Atherosclerosis is the major cause of heart disease. It is a chronic inflammatory response. Many factors contribute to this chronic inflammation. This review looks at
Autor:
Allan D. Angerio
Publikováno v:
Critical Care Nursing Quarterly. 29:152-156
Acute renal failure presents a serious and life-threatening problem in hospitalized patients. Current therapies address the systemic alterations in renal failure. Cellular changes also occur. These changes affect the glomerular filtration rate and th
Autor:
Allan D. Angerio
Publikováno v:
Critical Care Nursing Quarterly. 28:355-359
Current treatments for heart failure extend the life of the patient but do not stop the progression of the disease process. These treatments may not be addressing the underlying cause of cellular injury. The role of endothelin in cardiac remodeling a
Publikováno v:
Critical Care Nursing Quarterly. 28:208-213
Inflammatory bowel disease (IBD) appears to be an inappropriate response to an antigen that leads to chronic inflammation rather than repair. This review looks at the role of endothelin-1 (ET-1) as a proinflammatory agent in IBD. ET-1 antagonists in
Autor:
Allan D. Angerio, Nicole D. Lee
Publikováno v:
Critical Care Nursing Quarterly. 26:225-229
Sickle cell crisis may be more complex than a vaso-occlusive event in response to hypoxia. Endothelin-1 (ET-1) is a potent vasoconstrictor and mitogen secreted in response to hypoxia. ET-1 contributes to the vaso-occlusion and inflammation in sickle
Autor:
Allan D. Angerio, Dorothy A. Fink
Publikováno v:
Critical Care Nursing Quarterly. 25:67-73
Hypoxia-induced endothelin (ET) and vascular endothelial growth or permeability factor (VEGF) play an important role in tumor biology by promoting angiogenesis. Angiogenesis alters hemostasis and promotes thromboembolic disease (TED). Therapeutic ang
Autor:
Allan D. Angerio, Peter A. Kot
Publikováno v:
Critical Care Nursing Quarterly. 20:80-87
New insights into the closure of the ductus arteriosus may lead to more effective nonsurgical treatment in patent ductus arteriosus. ET-1 agonists may prove useful in future pharmacologic interventions.
Autor:
Allan D. Angerio, Peter A. Kot
Publikováno v:
Heart & Lung. 26:299-306
The vasoactive properties of endothelin-1 (ET-1) in the animal model vary with the tone of the pulmonary vessels, the dose level of ET-1, and the maturation of the vessels. The action of ET-1 is mediated by endothelium-derived nitric oxide, prostagla
Autor:
Peter W. Ramwell, Allan D. Angerio, Peter A. Kot, Edward C. Santoian, Marlowe J. Schneidkraut
Publikováno v:
Angiology. 43:163-168
The pulmonary vasoconstrictor responses to U-46619 and PGF2aare calcium dependent. The purpose of this investigation was to determine to what extent extracellular and intracellular calcium pools are utilized during the dose-de pendent pulmonary vasop
Autor:
Allan D. Angerio
Publikováno v:
Critical care nursing quarterly. 31(4)
Chronic obstructive pulmonary disease is a leading cause of morbidity and mortality. Understanding what happens at a cellular level will lead to more effective treatments. Interleukins and transforming growth factor-beta are important inflammatory me